Introduction
In October, the US Food and Drug Administration (FDA) approved another agent as a counterterrorism measure, Radiogardase. Also approved was Namenda (memantine) as a novel treatment of moderate to severe dementia of the Alzheimer's type.
This month's column reviews FDA new product approvals and labeling changes for:
|
Antidiabetic agents
|
Antidepressants
|
Antiviral agents
|
Cardiovascular agents
|
Counterterrorism agents
|
Estrogens
|
Ophthalmic Agents
|
Medscape Pharmacists. 2003;4(2) © 2003 Medscape
Cite this: November 2003 - Medscape - Nov 13, 2003.
Comments